Main Session: Collaborative Management of Patients with Advanced Estrogen Receptor-Positive Breast Cancer

At what point does a patient become a candidate for treatment with CDK inhibitors?

Lee S. Schwartzberg, MD, FACP
West Cancer Center


Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here
click me